Anthony Abbruscato

Long-term efficacy and safety of elamipretide in patients with Barth syndrome: 168-week open-label extension results of TAZPOWER

William Thompson, Ryan Manuel, Anthony Abbruscato et al. · Genetics in Medicine · 2024 · 36 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

ReCLAIM-2: A Randomized Phase II Clinical Trial Evaluating Elamipretide in Age-related Macular Degeneration, Geographic Atrophy Growth, Visual Function, and Ellipsoid Zone Preservation

Justis P. Ehlers, Allen Hu, David S. Boyer et al. · Ophthalmology Science · 2024 · 29 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +15

Natural history comparison study to assess the efficacy of elamipretide in patients with Barth syndrome

Brittany Hornby, William Thompson, Mohammed Almuqbil et al. · Orphanet Journal of Rare Diseases · 2022 · 21 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9

Safety, pharmacokinetics and pharmacodynamics of SBT‐020 in patients with early stage Huntington's disease, a 2‐part study

Marcus P.J. van Diemen, Ellen P. Hart, Anthony Abbruscato et al. · British Journal of Clinical Pharmacology · 2020 · 13 citations · Full text

Life Sciences, Neurology, Pharmacology +17

Genotype-specific effects of elamipretide in patients with primary mitochondrial myopathy: a post hoc analysis of the MMPOWER-3 trial

Amel Karaa, Enrico Bertini, Valério Carelli et al. · Orphanet Journal of Rare Diseases · 2024 · 10 citations · Full text

Life Sciences, Genetics, Pharmacotherapy +15